Published on .

After potential suitors SmithKline Beecham and Glaxo Wellcome went by the wayside, American Home Products Corp. tied the knot with Monsanto Co. in a $35 billion stock swap merger. The companies -- a new name is not yet decided -- are estimated to have 1998 sales of $23 billion.

The former AHP will get strength from Monsanto's G.D. Searle pharmaceutical unit, with a potential arthritis drug that could have other important uses.

Most Popular
In this article: